(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.17%) $78.61
(-1.50%) $2.16
(-0.11%) $2 328.70
(-0.34%) $27.52
(0.36%) $968.40
(0.09%) $0.929
(0.18%) $10.84
(0.08%) $0.797
(0.00%) $91.35
10.06% Kr. 7.77
@ Kr.8.10
Emitido: 6 may 2024 @ 08:45
Retorno: -4.07%
Señal anterior: may 6 - 07:34
Señal anterior:
Retorno: 0.00 %
Live Chart Being Loaded With Signals
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase...
Stats | |
---|---|
Volumen de hoy | 1.03M |
Volumen promedio | 1.59M |
Capitalización de mercado | 267.26M |
EPS | Kr.0 ( 2024-02-14 ) |
Last Dividend | Kr.0 ( N/A ) |
Next Dividend | Kr.0 ( N/A ) |
P/E | -1.410 |
ATR14 | Kr.1.549 (19.44%) |
Volumen Correlación
Ultimovacs ASA Correlación
10 Correlaciones Más Positivas | |
---|---|
AUSS.OL | 0.945 |
IDEX.OL | 0.94 |
LSG.OL | 0.931 |
NBX.OL | 0.93 |
EFUEL.OL | 0.911 |
TEL.OL | 0.907 |
ADE.OL | 0.902 |
AFG.OL | 0.887 |
ELIMP.OL | 0.885 |
SSG.OL | 0.872 |
10 Correlaciones Más Negativas | |
---|---|
FROY.OL | -0.962 |
TRE.OL | -0.9 |
NORSE.OL | -0.899 |
SPOG.OL | -0.843 |
ECIT.OL | -0.839 |
NODL.OL | -0.837 |
BWLPG.OL | -0.825 |
KAHOT.OL | -0.819 |
IWS.OL | -0.816 |
TRVX.OL | -0.815 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ultimovacs ASA Correlación - Moneda/Commodity
Ultimovacs ASA Finanzas
Annual | 2023 |
Ingresos: | Kr.0 |
Beneficio Bruto: | Kr.-2.77M (0.00 %) |
EPS: | Kr.-5.50 |
FY | 2023 |
Ingresos: | Kr.0 |
Beneficio Bruto: | Kr.-2.77M (0.00 %) |
EPS: | Kr.-5.50 |
FY | 2022 |
Ingresos: | Kr.0 |
Beneficio Bruto: | Kr.-2.65M (0.00 %) |
EPS: | Kr.-4.29 |
Financial Reports:
No articles found.
Ultimovacs ASA
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico